These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30712769)

  • 41. Visceral leishmaniasis in a lung transplant recipient: usefulness of highly sensitive real-time polymerase chain reaction for preemptive diagnosis.
    Opota O; Balmpouzis Z; Berutto C; Kaiser-Guignard J; Greub G; Aubert JD; Prod'hom G; Manuel O; Jaton K
    Transpl Infect Dis; 2016 Oct; 18(5):801-804. PubMed ID: 27495987
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leishmaniasis in immunosuppressed individuals.
    van Griensven J; Carrillo E; López-Vélez R; Lynen L; Moreno J
    Clin Microbiol Infect; 2014 Apr; 20(4):286-99. PubMed ID: 24450618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Re-emergence of visceral leishmaniasis in Gujarat, India.
    Sharma U; Redhu NS; Mathur P; Singh S
    J Vector Borne Dis; 2007 Sep; 44(3):230-2. PubMed ID: 17896628
    [No Abstract]   [Full Text] [Related]  

  • 44. Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: results from a seven-year retrospective study in Greece.
    Georgiadou SP; Stefos A; Spanakos G; Skrimpas S; Makaritsis K; Sipsas NV; Dalekos GN
    Int J Infect Dis; 2015 May; 34():46-50. PubMed ID: 25743761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Visceral Leishmaniasis Masquerading as Drug-Induced Pancytopenia in Lung Cancer Patients.
    Laroumagne S; Tronchetti J; Dutau H; Astoul P
    Curr Oncol; 2024 Apr; 31(4):2274-2277. PubMed ID: 38668071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A travel misadventure--visceral leishmaniasis in an immunocompetent patient.
    Delacour H; Roche C; Roche B; Morand C; Koeck JL
    J R Army Med Corps; 2010 Sep; 156(3):169-71. PubMed ID: 20919619
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visceral leishmaniasis in immunosuppressed Caucasian patient.
    Toqeer M; Rahman N; Whitehead MW; Lockwood D
    BMJ Case Rep; 2012 May; 2012():. PubMed ID: 22605859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current approaches to visceral leishmaniasis treatment in solid organ transplant recipients.
    Clemente WT; Mourão PHO; Aguado JM
    Expert Rev Anti Infect Ther; 2018 May; 16(5):391-397. PubMed ID: 29737887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia.
    Tamiru A; Tigabu B; Yifru S; Diro E; Hailu A
    BMC Infect Dis; 2016 Oct; 16(1):548. PubMed ID: 27724891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Treatment of visceral leishmaniasis in children].
    Minodier P; Noël G; Blanc P; Uters M; Retornaz K; Garnier JM
    Med Trop (Mars); 2007 Feb; 67(1):73-8. PubMed ID: 17506279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of visceral leishmaniasis: options and choice.
    Bhattacharya SK; Dash AP
    Lancet Infect Dis; 2016 Feb; 16(2):142-3. PubMed ID: 26867454
    [No Abstract]   [Full Text] [Related]  

  • 52. Leishmaniasis: an update of current pharmacotherapy.
    Sundar S; Chakravarty J
    Expert Opin Pharmacother; 2013 Jan; 14(1):53-63. PubMed ID: 23256501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Visceral Leishmaniasis in A Patient Presenting with Fever of Unknown Origin: A Case Report From a Low-endemic Region of Turkey.
    Jaiteh MB; Çalık Başaran N; Özışık L; Akman O; Hasanlı N; Tortop S; Özmen Çapın BB; Hüseyinova S; Üner A; İnkaya AÇ
    Turkiye Parazitol Derg; 2019 Dec; 43(4):210-212. PubMed ID: 31865658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Visceral leishmaniasis during pregnancy: A rare case report from Greece.
    Panagopoulos P; Mitsopoulos V; Papadopoulos A; Theodorou S; Christodoulaki C; Aloupogiannis K; Papantoniou N
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005134. PubMed ID: 28207741
    [No Abstract]   [Full Text] [Related]  

  • 55. You're the flight surgeon: visceral leishmaniasis.
    Zaleski SD
    Aviat Space Environ Med; 2012 Apr; 83(4):454-5. PubMed ID: 22462377
    [No Abstract]   [Full Text] [Related]  

  • 56. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Mediterranean visceral leishmaniasis].
    Marty P; Pomares C; Michel G; Delaunay P; Ferrua B; Rosenthal E
    Bull Acad Natl Med; 2011 Jan; 195(1):181-8. PubMed ID: 22039711
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal gammopathy in human leishmaniasis.
    Randi ML; Ruzzon E; Tezza F; Tezza F; Pacquola E; Fabris F
    Neth J Med; 2006 Feb; 64(2):50-1. PubMed ID: 16517989
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of Mediterranean visceral leishmaniasis.
    Gradoni L; Bryceson A; Desjeux P
    Bull World Health Organ; 1995; 73(2):191-7. PubMed ID: 7743590
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current diagnosis and treatment of visceral leishmaniasis.
    Mondal S; Bhattacharya P; Ali N
    Expert Rev Anti Infect Ther; 2010 Aug; 8(8):919-44. PubMed ID: 20695748
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.